Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Genenta Science SpA Sponsored ADR ( (GNTA) ) just unveiled an announcement.
Genenta Science S.p.A. and AGC Biologics S.p.A. have amended their Development and Master Services Agreement. The amendment introduces an Exclusive GMP Suite dedicated to Genenta’s cell therapy manufacturing, ensuring compliance with cGMP standards. This strategic move aims to enhance Genenta’s production capabilities, potentially improving efficiency and reliability in their manufacturing processes.
More about Genenta Science SpA Sponsored ADR
YTD Price Performance: -1.41%
Average Trading Volume: 13,930
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $89.25M
For detailed information about GNTA stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Amazon (NASDAQ:AMZN) Carries on With Grocery Store Plans
- Ford (NYSE:F) Faces Multiple Product Recalls
- ‘Favorable Trends,’ Says Top Investor About Super Micro Computer Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
